Structure‐based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles
Carriers are equally important as drugs. They can substantially improve bioavailability of
cargos and safeguard healthy cells from toxic effects of certain therapeutics. Recently …
cargos and safeguard healthy cells from toxic effects of certain therapeutics. Recently …
[HTML][HTML] Biomimetic nanoparticles for inflammation targeting
There have been many recent exciting developments in biomimetic nanoparticles for
biomedical applications. Inflammation, a protective response involving immune cells, blood …
biomedical applications. Inflammation, a protective response involving immune cells, blood …
[HTML][HTML] Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
Update on nanoparticle-based drug delivery system for anti-inflammatory treatment
H Wang, Y Zhou, Q Sun, C Zhou, S Hu… - … in Bioengineering and …, 2021 - frontiersin.org
Nanobiotechnology plays an important role in drug delivery, and various kinds of
nanoparticles have demonstrated new properties, which may provide opportunities in …
nanoparticles have demonstrated new properties, which may provide opportunities in …
[HTML][HTML] Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches
J Bejarano, M Navarro-Marquez, F Morales-Zavala… - Theranostics, 2018 - ncbi.nlm.nih.gov
Cardiovascular diseases are the leading cause of death worldwide. Despite preventive
efforts, early detection of atherosclerosis, the common pathophysiological mechanism …
efforts, early detection of atherosclerosis, the common pathophysiological mechanism …
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm
M Howard, BJ Zern, AC Anselmo, VV Shuvaev… - ACS …, 2014 - ACS Publications
Targeted nanomedicine holds promise to find clinical use in many medical areas.
Endothelial cells that line the luminal surface of blood vessels represent a key target for …
Endothelial cells that line the luminal surface of blood vessels represent a key target for …
Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets
Atherosclerosis, the primary cause of cardiovascular disease (CVD), is a chronic
inflammatory disorder in the walls of medium and large arteries. CVD is currently …
inflammatory disorder in the walls of medium and large arteries. CVD is currently …
[HTML][HTML] Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases
Inflammatory disease management poses challenges due to the complexity of inflammation
and inherent patient variability, thereby necessitating patient-specific therapeutic …
and inherent patient variability, thereby necessitating patient-specific therapeutic …
Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging
In the last decade, the biomedical applications of nanoparticles (NPs)(eg cell tracking,
biosensing, magnetic resonance imaging (MRI), targeted drug delivery, and tissue …
biosensing, magnetic resonance imaging (MRI), targeted drug delivery, and tissue …
Detection and treatment of atherosclerosis using nanoparticles
Atherosclerosis is the key pathogenesis of cardiovascular disease, which is a silent killer
and a leading cause of death in the United States. Atherosclerosis starts with the adhesion …
and a leading cause of death in the United States. Atherosclerosis starts with the adhesion …